1 – 16 of 16
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Ivacaftor therapy post myocardial infarction augments systemic inflammation and evokes contrasting effects with respect to tissue inflammation in brain and lung
(
- Contribution to journal › Article
-
Mark
Alterations to Cerebral Perfusion, Metabolite Profiles, and Neuronal Morphology in the Hippocampus and Cortex of Male and Female Mice during Chronic Exposure to a High-Salt Diet
(
- Contribution to journal › Article
-
Mark
Density of Sphingosine-1-Phosphate Receptors Is Altered in Cortical Nerve-Terminals of Insulin-Resistant Goto-Kakizaki Rats and Diet-Induced Obese Mice
2023) In Neurochemical Research(
- Contribution to journal › Article
- 2022
-
Mark
Therapeutic CFTR Correction Normalizes Systemic and Lung-Specific S1P Level Alterations Associated with Heart Failure
(
- Contribution to journal › Article
-
Mark
Restoring myocardial infarction-induced long-term memory impairment by targeting the cystic fibrosis transmembrane regulator
(
- Contribution to journal › Article
-
Mark
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation
(
- Contribution to journal › Article
-
Mark
Restoring heart failure-induced long-term memory impairment by targeting the cystic fibrosis transmembrane regulator
(
- Contribution to journal › Published meeting abstract
- 2021
-
Mark
Simvastatin therapy attenuates memory deficits that associate with brain monocyte infiltration in chronic hypercholesterolemia
(
- Contribution to journal › Article
-
Mark
Plasma S1P (Sphingosine-1-Phosphate) Links to Hypertension and Biomarkers of Inflammation and Cardiovascular Disease : Findings From a Translational Investigation
(
- Contribution to journal › Article
- 2020
-
Mark
Improving cerebrovascular function to increase neuronal recovery in neurodegeneration associated to cardiovascular disease
(
- Contribution to journal › Scientific review
-
Mark
Therapeutic Inhibition of Sphingosine Kinase SphK2 lowers Blood Pressure Levels in an Experimental Model of Hypertension by Reducing CD4+ T‐cell Responses
(
- Contribution to journal › Published meeting abstract
-
Mark
Targeting cerebrovascular sphingosine‐1‐phosphate signaling to treat heart failure‐induced brain dysfunction
(
- Contribution to journal › Published meeting abstract
- 2019
-
Mark
T-Cell Accumulation in the Hypertensive Brain: A Role for Sphingosine-1-Phosphate-Mediated Chemotaxis.
(
- Contribution to journal › Article
-
Mark
Targeting sphingosine-1-phosphate signaling to treat heart failure-induced memory deficits
(
- Contribution to journal › Published meeting abstract
-
Mark
Hypertension associated neuroinflammation and cognitive decline are attenuated by targeting the sphingosine-1-phosphate pathway
(
- Contribution to journal › Published meeting abstract
-
Mark
CFTR Therapeutics Normalize Cerebral Perfusion Deficits in Mouse Models of Heart Failure and Subarachnoid Hemorrhage
(
- Contribution to journal › Article